Adachi, Yayoi http://orcid.org/0000-0002-5134-8854
Asaga, Sota
Kumamaru, Hiraku
Kinugawa, Naoko
Sagara, Yasuaki
Niikura, Naoki
Jinno, Hiromitsu
Saji, Shigehira
Toi, Masakazu
Article History
Received: 5 April 2023
Accepted: 22 June 2023
First Online: 21 July 2023
Declarations
:
: HK reports received consultation fees from Mitsubishi-Tanabe Pharma Corporation and EPS Corporation and speaker fees from Chugai Pharmaceutical Co., Ltd. and Johnson and Johnson KK. HK and NK are affiliated with the Department of Health Quality Assessment at the University of Tokyo, a social collaboration department supported by the National Clinical Database, Johnson and Johnson K.K., Nipro Corporation, and Intuitive Surgical Sàrl. NN received honoraria from Astra Zeneca, Chugai, Daiichi Sankyo, Pfizer, Eli Lilly and MSD; and research funding from Chugai, Daiichi Sankyo, Pfizer, Eisai, Mochida and Novartis. SS received honoraria from Astra Zeneca, Chugai, Daiichi Sankyo, Eisai, Eli Lilly, Kyowa Kirin, MSD, Ono, Pfizer, Taiho and Takeda; and research funding from Astra Zeneca, Chugai, Daiichi Sankyo, MSD and Taiho. MT reports received honoraria from Chugai, Takeda, Pfizer, Kyowa-Kirin, Taiho, Eisai, Daiichi-Sankyo, AstraZeneca, Eli Lilly and companies, MSD, Exact Science, Novartis, Shimadzu, Yakult, Nippon Kayaku, Devicore Medical Japan, and Sysmex; and research funding from Chugai, Takeda, Pfizer, Taiho, JBCRG assoc., KBCRN assoc., Eisai, Eli Lilly, Daiichi-Sankyo, AstraZeneca, Astellas, Shimadzu, Yakult, Nippon Kayaku, AFI technology, Luxonus, Shionogi, GL Science, and Sanwa Shurui. YA, SA, NK, YS, HJ, and MT have no relevant financial or non-financial interests to disclose.
: This study was performed in accordance with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Aichi Cancer Center (5.8.2019/No.2019-1-042).